MARLBOROUGH, Mass., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will be participating in four upcoming investor conferences.
H.C. Wainwright 24th Annual Global Investment Conference (New York, NY) Presentation on Monday, September 12th at 11.30 AM ET
Morgan Stanley 20th Annual Global Healthcare Conference (New York, NY) Fireside chat on Wednesday, September 14th at 8:35 AM ET
Capital One Spatial Biology & Proteomics Summit (Virtual) Spatial Biology & Single Cell panel discussion on Wednesday, September 28th at 10:15 AM ET Executive panel discussion on Wednesday, September 28th at 1:00 PM ET
Bank of America Healthcare Innovation Forum (Virtual) Spatial Biology & Single Cell panel discussion on Thursday, September 29th at 11 AM ET
A live and archived webcast of the Morgan Stanley Glbal Healthcare Conference will be available on the “Investors” section of the Akoya website at https://investors.akoyabio.com/.
About Akoya Biosciences As The Spatial Biology Company®, Akoya Biosciences’ mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. Akoya offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research via its key platforms: PhenoCycler™, PhenoImager™ Fusion and PhenoImager HT. To learn more about Akoya, visit www.akoyabio.com.
Investor Contact: Priyam Shah Sr. Director, Investor Relations Akoya Biosciences, Inc. [email protected]
